ST Pharm Co.,Ltd. (KOSDAQ:237690)
South Korea · Delayed Price · Currency is KRW 99,700
-11,200 (-10.10%)
Aug 21, 2026, 3:30 PM KST
ST Pharm Market Cap
ST Pharm has a market cap or net worth of 2.08 trillion as of August 21, 2026. Its market cap has increased by 15.53% in one year.
Market Cap
2.08T
Enterprise Value
1.96T
Revenue
346.22B
Ranking
n/a
PE Ratio
30.10
Stock Price
99,700.00
ChartMarket Cap Chart
Since June 23, 2016, ST Pharm's market cap has increased from 902.04B to 2.08T, an increase of 130.74%. That is a compound annual growth rate of 8.57%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 2.08T | -15.65% |
| Dec 30, 2025 | 2.47T | 37.85% |
| Dec 30, 2024 | 1.79T | 40.37% |
| Dec 28, 2023 | 1.28T | -22.60% |
| Dec 29, 2022 | 1.65T | -36.55% |
| Dec 30, 2021 | 2.60T | 34.10% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 71.39T |
| Celltrion | 44.51T |
| ALTEOGEN | 21.13T |
| Samsung Epis Holdings | 9.03T |
| Hugel | 2.67T |
| D&D Pharmatech | 2.66T |
| Kolon TissueGene | 2.20T |
| OliX Pharmaceuticals | 2.20T |